Max Robotics — Global Service Robot Directory + US Certification

About

Mathias Bressel is a leading biostatistician whose work bridges surgical oncology and nuclear medicine, with a particular focus on prostate and rectal cancers. His research is defined by rigorous meta-analyses and innovative clinical trial design, most notably in the comparative effectiveness of minimally invasive surgeries. His landmark 2012 meta-analysis comparing robotic versus laparoscopic proctectomy for rectal cancer, cited over 219 times, provided critical evidence on surgical outcomes and helped shape modern colorectal practice. More recently, Bressel has been instrumental in advancing theranostics for high-risk prostate cancer. As a key biostatistician on the LuTectomy trial (2023), he helped demonstrate the feasibility of administering [177Lu]Lu-PSMA-617 prior to radical prostatectomy, a pioneering approach that has garnered 84 citations in just a short time. His work consistently combines methodological rigor with direct clinical relevance, making him a vital contributor to evidence-based urologic oncology.